Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Virology|July 1, 2023
A review of broadly protective monoclonal antibodies to treat Ebola virus diseasePramila Rijal, Francesca R Donnellan
Msphere|August 11, 2021
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike GlycoproteinRobert J Ragotte, David Pulido, Francesca R Donnellan, et al.
Cell Reports|June 22, 2026
Addition of blood-stage antibody enhances anti-sporozoite antibody protection in a humanized mouse model of Plasmodium falciparum infectionPayton Kirtley, Thomas Martinson, Francesca R Donnellan, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against Ebolavirus glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Npj Viruses|May 7, 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Cell Reports|April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated HumansPramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
Immunity|June 12, 2026
Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionBarnabas G Williams, Jordan R Barrett, Josefin Bartholdson Scott, et al.
Cell|June 18, 2019
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing AntibodiesDaniel G W Alanine, Doris Quinkert, Rasika Kumarasingha, et al.
Cell|July 26, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotypeJordan R Barrett, Dimitra Pipini, Nathan D Wright, et al.
Pageof 2